Dunhill Financial’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$583 Buy
4
+3
+300% +$419 ﹤0.01% 1082
2025
Q4
$156 Buy
+1
New +$157 ﹤0.01% 1200
2024
Q3
Sell
-630
Closed -$79.4K 968
2024
Q2
$79.4K Buy
+630
New +$98.7K 0.05% 114

Other funds holding RGEN

Dunhill Financial's RGEN Position: Q1 2026 in Review

Dunhill Financial increased its Repligen (RGEN) stake by 300% in Q1 2026, buying an estimated $419 and bringing the position to 4 shares worth $583. The position accounts for ﹤0.01% of the portfolio, ranked #1082.

Dunhill Financial first reported a position in RGEN in Q2 2024 and has held it in 3 quarters since. The position peaked at $79.4K in Q2 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Dunhill Financial held 4 shares of Repligen worth $583 as of Q1 2026.
  • Dunhill Financial bought 3 Repligen shares in Q1 2026, an estimated $419.
  • Repligen made up ﹤0.01% of Dunhill Financial's portfolio in Q1 2026, its #1082 holding.
  • Dunhill Financial first reported a position in Repligen in Q2 2024 and has held it in 3 quarters since.
  • Dunhill Financial's Repligen position peaked at $79.4K in Q2 2024.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Dunhill Financial's 13F filing for Q1 2026, filed 6 May 2026.